Table 1.
Summary of effects caused by mislocalized rhodopsin or drug treatment
| Condition | OS length, μm | OS/180 μm retina length | Nuclei/180 μm retina length |
|---|---|---|---|
| Rho-Dend2-1D4 | 20.0 ± 4.3 | 23.6 ± 1.1 | 115.7 ± 8.0 |
| RhoQ344Ter-Dend2 | 11.2 ± 2.6 | 17.5 ± 2.5 | 104.2 ± 5.7 |
| Untreated | 15.6 ± 4.4 | 24.9 ± 1.4 | 108.8 ± 9.1 |
| Digoxin | 11.1 ± 4.7 | 16.5 ± 2.6 | 106.9 ± 7.8 |
| Ouabain | 12.0 ± 4.6 | 19.3 ± 5.4 | 105.5 ± 10.0 |
| Wedelolactone | 14.4 ± 7.1 | 18.5 ± 1.5 | 103.0 ± 5.6 |
| Istaroxime | 13.0 ± 4.5 | 22.0 ± 2.2 | 114.5 ± 4.5 |
| TTX | 13.5 ± 4.5 | 19.1 ± 2.9 | 103.3 ± 12.6 |